Search
CDC Video showing N.Fowleri
- CDC
- Jul 21, 2017
- 0 min read
Recent Posts
See AllFDA Grants Profounda Orphan Drug Designation Approval for treatment of invasive candidiasis with Miltefosine - Invasive candidiasis is an...
top of page
Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO
bottom of page